Arcutis Biotherapeutics Inc

2026-09-14 20:02; UTC

Shares of Arcutis Biotherapeutics Inc. are advancing, having rebounded from an early session low amid broader market concerns over rising crude oil prices.

2026-09-11 19:46; UTC

Arcutis Biotherapeutics is gaining today, reaching earlier highs amid broader market reactions to Consumer Price Index data and interest rate speculation.

2026-09-10 23:06; UTC

Arcutis Biotherapeutics shares are lower in after-market hours, continuing a downward trend observed over the past three sessions. The price remains below the 20-day moving average.

2026-09-09 19:26; UTC

Arcutis Biotherapeutics is declining amid broader market pressure from rising crude oil prices, which reached $100.49 per barrel during Wednesday's session.

2026-09-08 23:41; UTC

Arcutis Biotherapeutics shares rose in after-market trading, marking a shift from the recent trend of higher daily closes since Tuesday's close.

2026-09-04 20:07; UTC

Arcutis Biotherapeutics granted 57,000 RSUs to new employees, supporting growth initiatives. Shares are higher since Thursday's close despite a pullback earlier in the session.

2026-09-01 20:01; UTC

Arcutis Biotherapeutics Inc. shares are lower today, trading significantly below the 20-day moving average amid rising oil prices and inflation concerns.

2026-08-31 19:36; UTC

Arcutis Biotherapeutics Inc shares are higher today, recovering from earlier losses despite no specific news to explain the price movement.

2026-08-28 22:56; UTC

Arcutis Biotherapeutics shares are higher in after-market trading, though no specific news was identified. Broader market conditions may influence this movement.

2026-08-26 20:08; UTC

Arcutis Biotherapeutics Inc shares are higher Wednesday, pulling back from session highs. Broader market fluctuations follow inflation data indicating rising consumer prices.

2026-08-25 19:36; UTC

Arcutis Biotherapeutics shares are gaining as board member Terrie Curran exercised options for 1,072 shares valued at $18,642, according to an SEC filing.

2026-08-24 19:16; UTC

Arcutis Biotherapeutics Inc. shares are trading lower, continuing a downward trend amid broader market dynamics and ahead of upcoming macroeconomic developments.

2026-08-21 19:56; UTC

Arcutis Biotherapeutics Inc. is trading lower despite Health Canada's approval of PrZORYVE® cream for pediatric atopic dermatitis. The stock continues a downward trend since Thursday.

2026-08-20 19:51; UTC

Arcutis Biotherapeutics Inc shares are lower despite Health Canada approving ZORYVE cream for pediatric atopic dermatitis, amid broader Biotechnology sector weakness.

2026-08-19 19:26; UTC

Shares of Arcutis Biotherapeutics Inc. are higher today, maintaining an upward trajectory despite a modest pullback from an early high earlier in the session.

2026-08-18 19:56; UTC

Arcutis Biotherapeutics Inc shares are higher today, following a notable peak earlier. The overall move remains positive since Monday's close amid rising Treasury yields.

2026-08-14 20:06; UTC

Shares of Arcutis Biotherapeutics Inc. are advancing today, despite mixed market sentiment following a reported decline in U.S. retail sales for July.

2026-08-13 19:36; UTC

Arcutis Biotherapeutics Inc is trading lower with no specific news identified. The stock is below its 20-day moving average after recent gains.

2026-08-12 19:46; UTC

Arcutis Biotherapeutics Inc is trading higher amid positive market sentiment following a favorable inflation report, contributing to gains in major U.S. indices.

2026-08-11 23:46; UTC

Arcutis Biotherapeutics shares are higher in after-market trading, reflecting broader market anticipation of modest inflation in the upcoming consumer price index report.

2026-08-10 19:36; UTC

Arcutis Biotherapeutics Inc is trading higher, rebounding from earlier lows. The stock remains below its 20-day moving average and near its one-month range.

2026-08-07 23:31; UTC

Arcutis Biotherapeutics granted 143,500 RSUs and options to new hires. Shares are trading higher in after-market hours following the announcement.

2026-08-06 22:16; UTC

Shares of Arcutis Biotherapeutics Inc. are trading higher in after-market hours, amid cautious investor sentiment following recent jobless claims data.

2026-08-05 23:02; UTC

Arcutis Biotherapeutics reports Q2 net product revenues of $129.9 million and raises full-year sales guidance to $525 million to $540 million. Shares rise in after-market trading.

2026-08-04 19:46; UTC

Arcutis Biotherapeutics is advancing during Tuesday's session amid a broader market boost from declining crude oil prices, easing inflation concerns.

2026-08-03 21:01; UTC

Arcutis Biotherapeutics Inc shares are lower in after-market trading, continuing a decline despite broader market gains and optimism over lower oil prices.

2026-07-31 20:03; UTC

Arcutis Biotherapeutics Inc shares are lower today, continuing a decline since Thursday's close amid broader weak performance and no specific news identified.

2026-07-30 23:51; UTC

Arcutis Biotherapeutics shares are lower in after-market trading, reflecting a broader decline since Thursday's close amid mixed Asian equity performance and geopolitical concerns.

2026-07-29 19:19; UTC

Arcutis Biotherapeutics Inc. shares are lower as market sentiment reflects concerns over the Federal Reserve's upcoming monetary policy announcement amid inflationary pressures.

2026-07-28 18:06; UTC

Arcutis Biotherapeutics Inc. shares are higher today, supported by a broader rally in biotechnology stocks, despite no specific company news identified.